Cancer is a disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body. Cancer begins when genetic changes interfere with this orderly process. Cells start to grow uncontrollably. These cells may form a mass called a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread. Different types of cancer are Carcinomas which include prostate cancer, breast cancer, lung cancer, and colorectal cancer, Sarcomas, Leukemias and Lymphomas.

Why I3T Focuses on that:

I3T is also an Advanced Diagnostic Centers. Clinical trials can help researchers find new ways to prevent and detect cancer, and they can also help improve the quality of life for patients during and after treatment.

Depending on tolerance, you may either feel lip-licking or nauseous with a dish of Chinese Mitten Crab before you. Foods apart, the term ‘Cancer’ was coined after this very decapod crustaceans back in the BC time to identify diseases manifesting projection from a growing mass in organ resembling the shape of a crab. This term collectively defines the uncontrolled and abnormal growth of cells in body beyond their natural boundaries. Globally, about 20% of people, irrespective of sex, are estimated to develop cancer in their lifetime at present days with a mortality rate of about 12% and 9% respectively, in men and women. Physical carcinogens (UV, ionizing radiation), chemical carcinogens (tobacco smoking, Arsenic poising through contaminated drinking water, asbestos inhalation, aflatoxin consumption through food etc.) and biological carcinogens (virus, bacteria, parasites) jeopardies with person’s generic materials leading to the transformation of normal cells to cancerous cells in a multi-stage process. Breast cancer covers about a quarter of all types diagnosed in women at recent time, along with noticeable contribution from colorectal, lung, cervical and thyroid. For men, lung and prostate cancers are reported to be most prevalent, comprised about 33% of all male cancers, with contributions from colorectal, liver, stomach etc.

At I3TK, we set our focus to carry out translational research on molecular characterization of pathophysiological features of different cancer types, identification of tumor-specific new prognostic and diagnostic markers and development of novel therapeutic interventions to reduce the disease burden. In conjunction with the Advanced Diagnostic Centre, we target to strengthen the arms of treatment and palliative care and help implementing the public health plans consist of the community and home-based trauma management.